News & Views
Gentronix Announces LSG Agreement
Mar 02 2011
Innovative biotechnology company Gentronix (Manchester, UK) is pleased to announce a new agreement with LSG Corporation (Tokyo, Japan).
The deal enables introduction of the GreenScreen® HC range of human cell-based genotoxicity assays across Japan, allowing scientists to accelerate the pace of drug discovery and development.
As a subsidiary of EPS Co, Ltd, one of the largest clinical research organisations in Japan, LSG was considered the ideal partner to promote the benefits of GreenScreen assays in this key market.
Steve Beasley, Commercial Director at Gentronix said “We are delighted to have signed this agency agreement with LSG Corporation. LSG’s experience and extensive contacts in the Japanese life sciences and toxicology sectors will help to further develop our customer base in this important market.”
Digital Edition
LMUK 49.7 Nov 2024
November 2024
News - Research & Events News - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan